Preclinical study of the medicinal plants for the treatment of malignant melanoma.
Fatma Aydoğmuş-ÖztürkHumera JahanMehmet ÖztürkKeriman GünaydınMouhamat Iqbal ChoudharyPublished in: Molecular biology reports (2020)
Melanoma is the most aggressive type of skin cancer and originates from pigment-containing cells called melanocytes. The incidence of melanoma has been increasing worldwide. In the current study, the cytotoxic and photo-cytotoxic activities of different medicinal plants from Lamiaceae (Salvia cedronella, Salvia chionantha, and Salvia adenophylla), Asteraceae (Klasea kurdica, Klasea bornmuelleri, and Achillea millefolium), Apiaceae (Cuminum cyminum, and Anethum graveolens), and Polygonaceae (Rumex crispus) families were studied against HT 144 (Human malignant melanoma) cancer cell lines. The activities were performed by employing the MTT assay. Moreover, the apoptotic effects of the plant extracts were investigated by flow cytometry with annexin V/PI dual staining technique. The production of intracellular ROS by DCFH-DA technique and the effects of TNF-α secretion on apoptosis were also investigated. All plant extracts exhibited cytotoxic, and photo-cytotoxic effects against HT 144 cancer cells. Salvia species and Klasea species induced apoptosis via intracellular ROS generation secreted by TNF-α. On the other hand, A. millefolium, C. cyminum, A. graveolens, and R. crispus extracts induced apoptosis due to the intracellular generation of ROS, but, via the different pathway. In conclusion, this study indicates that the tested medicinal plant extracts have the potential in the treatment of melanoma.
Keyphrases
- induced apoptosis
- endoplasmic reticulum stress
- oxidative stress
- cell death
- skin cancer
- reactive oxygen species
- signaling pathway
- flow cytometry
- rheumatoid arthritis
- dna damage
- endothelial cells
- cell cycle arrest
- stem cells
- mesenchymal stem cells
- mass spectrometry
- risk factors
- risk assessment
- high throughput
- climate change
- squamous cell carcinoma
- cell wall
- genetic diversity
- drug discovery
- pi k akt